The estrogenic status of patients with breast cancer may influence the prognosis and the response to treatment and is currently assessed by immunological measurement of serum estradiol...
Keywords: breast cancer, estrogenic activity, MELN cells, recombinant bioassay, serum
08/2004 | Clinical Chemical Laboratory Medicine, Walter de Gruyter